Drug Profile
Perfosfamide
Alternative Names: 4-HC; NSC 181815; PergamidLatest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator MGI Pharma
- Developer MGI Pharma; SuperGen
- Class Antineoplastics; Phosphoramide mustards; Small molecules
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Leukaemia
Most Recent Events
- 23 Aug 2001 NCI to fund a phase III study in AML patients in the US
- 24 Jan 1995 Discontinued-II for Leukaemia (myeloablation) in USA (Unknown route)